Archive for July 13th, 2012

AVII reverse split and name change. CPRX Phase 2b data due September. AMPE offering

Jul 13, 2012 1 Comment by

AVI BioPharma, Inc. (NASDAQ: AVII)  announced that it has changed its name to Sarepta Therapeutics, Inc.  (NASDAQ: SRPT)  and also effected a 1-for-6 reverse split. Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX)  announced that it expects to report top-line results from its CPP-109 (vigabatrin) Phase 2b trial around the end of September 2012 versus the previous guidance of early in […]

Daily News Read more